Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: Circulation. 2011 Jun 27;124(3):280–288. doi: 10.1161/CIRCULATIONAHA.110.991299

Table 6.

Association of 4-Year Major Adverse Clinical Events in Various SVG Groups With and Without Graft Failure in the Angiographic Cohort

Outcomes s-SVG Only and No
Graft Failures
(n = 700)
s-SVG Only and
≥1 Graft Failure
(n = 499)
m-SVG With or Without
s-SVG and No Graft
Failures (n = 341)
s-SVG and m-SVG With
≥1 s-SVG Failure and
No m-SVG Failures
(n = 89)
m-SVG With or Without
s-SVG with ≥1 m-SVG
Failure and No s-SVG
Failure (n = 123)
s-SVG and m-SVG
With 1 m-SVG
and ≥1 m-SVG
Failures (n = 77)
Events that include
only those during
or after protocol
angiography
(excludes events
before this), n
682 425 332 85 107 59
Death, MI or
revascularization
13.8 24.3 14.6 20.2 27.7 41.1
Death or MI 7.0 8.4 9.5 4.9 11.8 6.9
Death or
revascularization
13.4 23.6 13.7 18.9 26.8 41.1
Death 5.8 7.2 7.4 3.6 9.9 5.2

Values are presented as percentages, unless otherwise indicated.

SVG, saphenous vein graft; s-SVG = saphenous vein graft with only 1 distal target; m-SVG, saphenous vein graft with >1 distal target; and MI, myocardial infarction.